BJ
BIENAIME JEAN JACQUES disclosed purchase in Keros Therapeutics Inc
BIENAIME JEAN JACQUES disclosed a purchase transaction in Keros Therapeutics Inc (KROS) on 2026-05-19.
Action
Purchase
Capital
$10,580 reported value
Insider Form 4 Activity1 evidence source
Why it matters
This signal is anchored to the Form 4 disclosure date from Dataroma insider data.